Annual Drug Patent Expirations for JESDUVROQ Jesduvroq is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Glaxosmithkline drug JESDUVROQ appeare…
This chart shows the drugs with the most patents in South Africa. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical drugs have the most drug patents in South Afric…
Which pharmaceutical drugs have the most drug patents in South Africa? Read Post »
Annual Drug Patent Expirations for TRIKAFTA+%28COPACKAGED%29 Trikafta (copackaged) is a drug marketed by Vertex Pharms Inc and is included in two NDAs. It is available from one supplier. There are…
The post New patent for Vertex Pharms drug TRIKAFTA (C…
New patent for Vertex Pharms drug TRIKAFTA (COPACKAGED) Read Post »
Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent for Janssen Biotech drug ERLEADA appeared first on DrugPa…
Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent for Astrazeneca drug LYNPARZA appeared first…
Annual Drug Patent Expirations for NYMALIZE Nymalize is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for Azurity drug NYMALIZE appeared first on DrugPa…
Annual Drug Patent Expirations for KALYDECO Kalydeco is a drug marketed by Vertex Pharms Inc and Vertex Pharms and is included in two NDAs. It is available from one supplier.…
The post New patent for Vertex Pharms drug KALYDECO appeared first on DrugPa…
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPatentWatch.com
The post New tentative approval for Mylan Gmbh drug trastuzumab-dkst appeared …
New tentative approval for Mylan Gmbh drug trastuzumab-dkst Read Post »
This chart shows the pharmaceutical companies with the most patents in Greece. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Greece? Read Post »
Annual Drug Patent Expirations for WEGOVY Wegovy is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are five patents protecting…
The post New patent for NOVO drug WEGOVY appeared first on DrugPatentWatch – …